Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members
about
The genetics and neuropathology of frontotemporal lobar degenerationMolecular Pathways Bridging Frontotemporal Lobar Degeneration and Psychiatric DisordersExpanding the Repertoire of Biomarkers for Alzheimer's Disease: Targeted and Non-targeted ApproachesPhenotypic Heterogeneity of Monogenic Frontotemporal DementiaMechanisms of granulin deficiency: lessons from cellular and animal modelsPotential roles of microglial cell progranulin in HIV-associated CNS pathologies and neurocognitive impairmentProgranulin: at the interface of neurodegenerative and metabolic diseasesThe advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier)Granulin knock out zebrafish lack frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis pathologyA neurodegenerative disease mutation that accelerates the clearance of apoptotic cellsProgranulin Deficiency Promotes Circuit-Specific Synaptic Pruning by Microglia via Complement Activation.Progranulin gene variability and plasma levels in bipolar disorder and schizophrenia.Accumulation of multiple neurodegenerative disease-related proteins in familial frontotemporal lobar degeneration associated with granulin mutation.Sporadic corticobasal syndrome due to FTLD-TDP.Progranulin is neurotrophic in vivo and protects against a mutant TDP-43 induced axonopathyRecent insights into the molecular genetics of dementiaSuberoylanilide hydroxamic acid (vorinostat) up-regulates progranulin transcription: rational therapeutic approach to frontotemporal dementia.Biomarkers in frontotemporal lobar degenerations--progress and challenges.Progranulin protein levels are differently regulated in plasma and CSF.Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggest a role for progranulin in successful aging.Clinical phenotypes and genetic biomarkers of FTLD.Sortilin-mediated endocytosis determines levels of the frontotemporal dementia protein, progranulin.Genome-wide screen identifies rs646776 near sortilin as a regulator of progranulin levels in human plasma.TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers.Association between GRN rs5848 polymorphism and Parkinson's disease in Taiwanese populationrs5848 polymorphism and serum progranulin levelAssociation of TMEM106B gene polymorphism with age at onset in granulin mutation carriers and plasma granulin protein levels.Brain progranulin expression in GRN-associated frontotemporal lobar degenerationA network of RNA and protein interactions in Fronto Temporal Dementia.Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine.Low plasma progranulin levels in children with autism.TMEM106B a novel risk factor for frontotemporal lobar degenerationInteractions between traumatic brain injury and frontotemporal degeneration.Progranulin: a growth factor, a novel TNFR ligand and a drug targetPlasma levels of progranulin and interleukin-6 in frontotemporal lobar degeneration.Membrane orientation and subcellular localization of transmembrane protein 106B (TMEM106B), a major risk factor for frontotemporal lobar degeneration.Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementia.Prosaposin facilitates sortilin-independent lysosomal trafficking of progranulin.Mutation Frequency of the Major Frontotemporal Dementia Genes, MAPT, GRN and C9ORF72 in a Turkish Cohort of Dementia Patients.Progranulin: a proteolytically processed protein at the crossroads of inflammation and neurodegeneration.
P2860
Q24615201-7D19BCAC-A07D-4026-9E55-F2CA3A55B36FQ26766487-29B6EBCD-9434-481B-BD71-BB2025348EA7Q26770708-EE44AE28-8FE6-467F-8667-73C8CA54EAB6Q26782984-CADE35D7-EE15-4AAD-8DC2-14DFE918106BQ26824221-B9E07F92-B2C3-450C-8FE5-8148A5AAF599Q27011876-995E0A3D-1A33-4CE9-8787-7656F18D7817Q27024421-FECDF29C-81F8-4D6E-A0FE-FA8F4FF70448Q28485924-BF3FF931-D754-439C-9B33-E0638309E8B5Q28544656-AAA56B53-8C81-4B95-98DF-306F66E153F6Q30498840-03BA937C-63DC-4862-9875-2DB5FBFAB6F6Q30754508-29910805-4634-45C7-94FE-1264ADDE6ABAQ31055209-CD763255-4B28-4649-8680-53304C24B555Q33685394-B609BE9A-3569-4877-B811-7E2A3ED7672BQ33703433-3C62BF57-7243-4ECF-BBB0-C532167A74CCQ33725391-65609502-D1FF-46C9-B5BC-90E36E2B200CQ33830518-F059BC7F-7582-4507-A09F-39411FC3B845Q33859252-A3D62F5E-5D45-4120-B5D8-0C01812B46D8Q33893515-CC66E38D-303D-46D9-A56C-B7CA8BADF0EAQ33927199-C7B4B7CB-5B00-40DB-BC8B-6370975F0BA5Q33947272-90DD2CD4-B273-4FE9-A171-3E61E681B979Q34243054-F3E45869-5315-4894-BEF1-73057CD08265Q34346014-B05F5C28-E3A6-4614-AC36-30440421F706Q34381669-BB8ABD98-54E1-4ECA-96A6-AA123F83C614Q34555400-946C9725-ADA1-4555-8366-D33E0AC39E66Q34559477-84D1E24C-8880-4FF8-B848-9B18DC59F955Q34891810-72EEE69E-8C9A-45B6-9485-EACB993727B7Q34959322-62C5EE5A-DFC2-47E8-BD57-C540B90831B0Q35014879-05637723-3E12-4061-91C2-3FD66000A8C2Q35194634-6DE23B9A-70CA-41D0-9FF7-FA0A73756AC2Q35204586-23AA9059-9BD9-41DF-8496-B120D3E53BE3Q35240854-C5F16BF0-A6F9-432F-9D91-982C4FA9B3DDQ35512313-64F00803-4A94-46F4-9954-97783ADCEDFCQ35593187-C867ADD6-FFAD-4A52-BAB5-5E4EC4463F6CQ35601050-BEF3991B-4B22-4D49-B47E-3CBB8D6EDCB5Q35859333-5EA7FF98-470D-4692-B156-063FA645E468Q36003800-19A757D8-37E6-4315-BA05-A0E50F5D044BQ36061223-5F45F85E-7D93-4A15-9D63-365334413F02Q36078240-842C024C-B0B4-4488-BABA-43FCF715ACA7Q36134488-61867150-EB2E-4FD6-8E11-219FE79F06E3Q36294670-27A14422-3A67-4CE7-BF83-65F7911F75AD
P2860
Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Plasma progranulin levels pred ...... nd asymptomatic family members
@en
Plasma progranulin levels pred ...... d asymptomatic family members.
@nl
type
label
Plasma progranulin levels pred ...... nd asymptomatic family members
@en
Plasma progranulin levels pred ...... d asymptomatic family members.
@nl
prefLabel
Plasma progranulin levels pred ...... nd asymptomatic family members
@en
Plasma progranulin levels pred ...... d asymptomatic family members.
@nl
P2093
P2860
P50
P356
P1433
P1476
Plasma progranulin levels pred ...... nd asymptomatic family members
@en
P2093
Anne Rovelet-Lecrux
Bradley Boeve
Gina Bisceglio
Julia Crook
Karen Kuntz
Katie Swanson
Matt Baker
Neill R Graff-Radford
NiCole Finch
Rebecca Surtees
P2860
P304
P356
10.1093/BRAIN/AWN352
P407
P577
2009-01-21T00:00:00Z